METHYL 7-BROMO-2,3-DIHYDRO-2-OXO-5-(2-PYRIDINYL)-1H-1,4-BENZODIAZEPINE-3-PROPANOATE
UNII RWQ4DF6GD8

Substance Identification & Data

This profile provides standardized clinical and technical data for Methyl 7-bromo-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1h-1,4-benzodiazepine-3-propanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RWQ4DF6GD8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 308242-81-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

RWQ4DF6GD8

CAS Registry Number

308242-81-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

METHYL 7-BROMO-2,3-DIHYDRO-2-OXO-5-(2-PYRIDINYL)-1H-1,4-BENZODIAZEPINE-3-PROPANOATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H16BrN3O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

PITXBYGUVDYTBQ-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

67069239

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

COC(=O)CCC1C(=O)Nc2ccc(cc2C(=N1)c3ccccn3)Br

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Methyl 7-bromo-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1h-1,4-benzodiazepine-3-propanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.